1,958
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure

, , , , &
Pages 503-509 | Received 27 Oct 2015, Accepted 26 Oct 2016, Published online: 09 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sajjad Ahmad, Bilal Shaker, Faisal Ahmad, Saad Raza & Syed Sikander Azam. (2019) Moleculer dynamics simulaiton revealed reciever domain of Acinetobacter baumannii BfmR enzyme as the hot spot for future antibiotics designing. Journal of Biomolecular Structure and Dynamics 37:11, pages 2897-2912.
Read now
Abdurrahman Olğaç, Ilkay Erdogan Orhan & Erden Banoglu. (2017) The Potential Role of In Silico Approaches to Identify Novel Bioactive Molecules from Natural Resources. Future Medicinal Chemistry 9:14, pages 1665-1686.
Read now

Articles from other publishers (11)

Leila Moradihaghgou, Reinhard Schneider, Bahram Maleki Zanjani & Taher Harkinezhad. (2023) Comparative Computational Screening of Natural-based Partial Agonists for PPARγ Receptor. Medicinal Chemistry 19:6, pages 594-618.
Crossref
Jennifer Lagoutte-Renosi, Florentin Allemand, Christophe Ramseyer, Semen Yesylevskyy & Siamak Davani. (2022) Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives. Drug Discovery Today 27:4, pages 985-1007.
Crossref
Qirong Lu, Pu Guo, Jingchao Guo, Irma Ares, Bernardo Lopez-Torres, María-Rosa Martínez-Larrañaga, Xu Wang, Arturo Anadón & María-Aránzazu Martínez. (2021) Targeting peroxisome proliferator-activated receptors: A new strategy for the treatment of cardiac fibrosis. Pharmacology & Therapeutics 219, pages 107702.
Crossref
Fariborz Moghadam, Mehdi Hajian, Shiva Rouhollahi Varnosfaderani, Farnoosh Jafarpour & Mohammad Hossein Nasr Esfahani. (2021) Effect of rosiglitazone on developmental competence of mouse embryos treated with lipopolysaccharide. Theriogenology 161, pages 57-64.
Crossref
Yannick Fotio, Anna Maria Borruto, Federica Benvenuti, Gregory Demopulos, George Gaitanaris, Marisa Roberto & Roberto Ciccocioppo. (2020) Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats. Neuropsychopharmacology 46:2, pages 360-367.
Crossref
Joe Reynolds, Sophie Malcomber & Andrew White. (2020) A Bayesian approach for inferring global points of departure from transcriptomics data. Computational Toxicology 16, pages 100138.
Crossref
Liwei Wu, Chuanyong Guo & Jianye Wu. (2020) Therapeutic potential of PPARγ natural agonists in liver diseases. Journal of Cellular and Molecular Medicine 24:5, pages 2736-2748.
Crossref
Yi Shen, Hongbo Chi, Jinhu Zhou, Lifei Luo, Qian Tu, Cancan Qi & Zuhua Gao. (2018) Structure-Based Stepwise Screening of PPARγ Antagonists as Potential Competitors with NCOA1 Coactivator Peptide for PPARγ CIS Site. International Journal of Peptide Research and Therapeutics 25:4, pages 1369-1377.
Crossref
Sreenivasa C Ramaiahgari, Scott S Auerbach, Trey O Saddler, Julie R Rice, Paul E Dunlap, Nisha S Sipes, Michael J DeVito, Ruchir R Shah, Pierre R Bushel, Bruce A Merrick, Richard S Paules & Stephen S Ferguson. (2019) The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration Modeling. Toxicological Sciences 169:2, pages 553-566.
Crossref
Bin Chen, Huiqiang Wang, Zhun Wu, Bo Duan, Peide Bai, Kaiyan Zhang, Wei Li, Jiaxin Zheng & Jinchun Xing. (2017) Conformational stabilization of FOX–DNA complex architecture to sensitize prostate cancer chemotherapy. Amino Acids 49:7, pages 1247-1254.
Crossref
Minghua Xian, Tingting Wang, Wen Zhang, Jinhuan Gao, Yi Zhang, Defeng Li, Junying Wei & Hongjun Yang. (2017) Yixinshu ameliorates hippocampus abnormality induced by heart failure via the PPARγ signaling pathway . RSC Advances 7:84, pages 53415-53421.
Crossref